Physician profile
Richard King
NPI 1861481350
$646.72
in general payments reported to CMS, 2019-2025
8 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $17.70 · 2021: $15.92 · 2023: $27.74 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.05 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrocision, INC. | $277.46 | 2025 | Tenjet |
| Novo Nordisk INC | $143.49 | 2019-2025 | Ozempic |
| Mannkind Corporation | $69.82 | 2025 | |
| Pfizer INC. | $55.66 | 2019 | |
| Sanofi-Aventis U.S. LLC | $40.98 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.74 | 2023 | Tradjenta, Jardiance |
| Novartis Pharmaceuticals Corporation | $15.92 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.